UNITED STATES  

SECURITIES AND EXCHANGE COMMISSION  

Washington, D.C. 20549  

FORM 8-K  

Current Report Pursuant  

to Section 13 or 15(d) of the  

Securities Exchange Act of 1934  

Date of Report (Date of earliest event reported) January 27, 2016  

HOLOGIC, INC.  

(Exact Name of Registrant as Specified in Its Charter)  

DELAWARE  

(State or Other Jurisdiction of Incorporation)  

 1-36214   04-2902449 

 (Commission File Number)   (I.R.S. Employer Identification No.)  

 250 Campus Drive, Marlborough, MA   01752 

 (Address of Principal Executive Offices)   (Zip Code)  

(508) 263-2900  

(Registrant’s Telephone Number, Including Area Code)  

(Former Name or Former Address, if Changed Since Last Report) 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 

 ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   

 ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   

 ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   

 ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   

Item 2.02 Results of Operations and Financial Condition. 

On January 27, 2016, Hologic, Inc. issued a press release announcing its financial results for the first quarter ended December 26, 2015. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference. 

Limitation on Incorporation by Reference. The information furnished in this Item 2.02, including the press release attached hereto as Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as set forth by specific reference in such a filing.  

Cautionary Note Regarding Forward-Looking Statements. Except for historical information contained in the press release attached as an exhibit hereto, the press release contains forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these statements. Please refer to the cautionary note in the press release regarding these forward-looking statements. 

Item 9.01 Financial Statements and Exhibits. 

(d) Exhibits. 

 Exhibit Number   Description 

 99.1    Press release dated January 27, 2016 of Hologic, Inc. announcing its financial results for the first quarter ended December 26, 2015.   

SIGNATURES  

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 

  [DATA_TABLE_REMOVED] 

EXHIBIT INDEX 

 Exhibit Number   Description 

 99.1    Press release dated January 27, 2016 of Hologic, Inc. announcing its financial results for the first quarter ended December 26, 2015.